STING1 and cancer: In summary, POLθ inhibition in HR-deficient TNBC and PDAC mouse models led to cGAS-STING-mediated expression of type I interferons known to be required for optimal immunological control of cancer, thereby resulting in increased immunogenicity of otherwise immunosuppressed tumors such as PDAC43.